source
- FDA approves Labcorp's BRAF melanoma companion diagnosticThe FDA has granted approval to Labcorp's companion diagnostic for advanced melanoma patients with specific BRAF mutations. The test, called PGDx elio tissue complete CDx, uses next-generation seq…
- Arpeggio Biosciences shuts down after Nrf2 drug program encounters off-target toxicityArpeggio Biosciences, founded in 2018 in Boulder, Colorado, built its platform around a large nascent‑RNA sequence database and aimed to develop a small‑molecule degrader of the Nrf2 transcription…